Brielle Benyon
CURE Magazine
New Jersey, United States
Contact Brielle
Discover and connect with journalists and influencers around the world, save time on email research, monitor the news, and more.
| Recent: |
|
| Past: |
|
Past articles by Brielle:
FDA Grants Regular Approval to Jemperli for Endometrial Cancer Subset
The FDA granted a regular approval to patients with recurrent or advanced dMMR endometrial cancer. → Read More
White House Provides Cancer Moonshot Updates, Mets Broadcaster Reveals Cancer Diagnosis and More
From funding updates on the Cancer Moonshot to Howie Rose’s bladder cancer diagnosis and more, here’s what’s happening in the oncology space this week. → Read More
FDA Approves Trodelvy for HER2-Negative, HR-Positive Metastatic Breast Cancer
The Food and Drug Administration approved Trodelvy for patients with pretreated, unresectable HR-positive, HER2-negative metastatic breast cancer. → Read More
Brazilian Soccer Legend, Pelé, Dies of Colon Cancer Complications
Pelé died on Dec. 29, 2022, from complications related to his colon cancer. → Read More
FDA Approves Tablet Version of Calquence to Treat Multiple Blood Cancers
The tablet version of Calquence, which was approved by the FDA for the treatment of chronic lymphocytic leukemia, small lymphocytic leukemia and relapsed/refractory mantle cell lymphoma, may be taken alongside other drugs to reduce gastric-related side effects. → Read More
Educated Patient® Prostate Cancer Summit Novel Agents Presentation: May 21, 2022
Watch Dr. Tian Zhang, from UT Southwestern Medical Center, discuss novel agents, during the CURE Educated Patient Prostate Cancer Summit. → Read More
FDA Approves Kymriah for Relapsed/Refractory Follicular Lymphoma
Kymriah, a CAR-T cell therapy, was approved by the Food and Drug Administration for the treatment of patients with pretreated, relapsed/refractory follicular lymphoma. → Read More
Madeleine Albright, First Female Secretary of State and ‘Courageous Woman,’ Dies of Cancer
Madeleine Albright, the first female secretary of state, died of cancer earlier today. She was 84 years old. → Read More
The 5 Most-Read Breast Cancer Articles of 2021
CURE® takes a look back at its top-performing breast cancer articles of 2021. → Read More
Top 5 Kidney Cancer Articles From 2021
Take a look back at some of the major milestones in kidney cancer that were achieved in 2021. → Read More
Top 5 Lung Cancer-Related Stories of 2021
CURE® took a look back at our most-read lung cancer stories from this year. → Read More
Top 5 Skin Cancer-Related Articles of 2021
Here’s a look back at CURE®’s top-performing melanoma content from the year 2021. → Read More
3 Things to Look for When Reading Cancer Research
Knowing the type, phase and eligibility criteria is key in reading cancer research. → Read More
FDA Approves Tecartus for Relapsed/Refractory Acute Lymphoblastic Leukemia
The FDA approved Tecartus, a CAR-T cell therapy, for the treatment of patients with relapsed/refractory acute lymphoblastic leukemia. → Read More
What’s Next in Myeloproliferative Neoplasm Treatment?
There are promising drugs for myeloproliferative neoplasms coming down the pipeline. → Read More
An Overview of Oncology FDA Approvals: Summer 2021
Multiple cancer drugs have been approved by the FDA in the last few months. → Read More
Long-Term Pain Management in Blood Cancers: When Are Opioids Appropriate?
Blood cancer survivors are living longer than ever, making safe pain management an important concern. → Read More
Common Questions on Medical Marijuana
An expert discusses the most common reasons his patients ask him about medical marijuana. → Read More
4 Tips for Cancer Survivors on Summer Vacation
CURE® offers tips to stay relaxed and healthy during the summer months. → Read More
Study Analyzes Quality of Life Research on Patients With CLL and Their Caregivers
More research is needed on how a chronic lymphocytic leukemia diagnosis can affect patients and their caregivers. → Read More